Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

PRP is more effective than minoxidil and placebo for treating hair loss.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Finasteride and dutasteride do not significantly change beard thickness in men.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Taking five small dutasteride capsules is the same as taking one larger capsule.

Laser and minoxidil combo promotes better hair growth than minoxidil alone, safely.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Minoxidil and photobiomodulation together improve hair growth better than minoxidil alone.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

PRP treatment helps 70.1% of hair loss patients after two sessions.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.